Brief: Axonics® Files Pma Supplement With FDA For Fourth Generation Rechargeable Neurostimulator
May 31 (Reuters) - Axonics Inc AXNX.O :
* AXONICS® FILES PMA SUPPLEMENT WITH FDA FOR FOURTH
GENERATION
RECHARGEABLE NEUROSTIMULATOR
* AXONICS INC - ANTICIPATES RECEIVING FDA APPROVAL FOR
FOURTH
GENERATION RECHARGEABLE INS IN Q4 OF 2022
* AXONICS INC - EXPECTS TO BEGIN SHIPPING NEW DEVICE FOURTH
GENERATION RECHARGEABLE INS TO CUSTOMERS IN Q1 OF 2023
Source text for Eikon: ID:nBw73JzNqa
Further company coverage: AXNX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Axonics
See all newsBrief: Boston Scientific Closes Acquisition Of Axonics, Inc.
Axonics Inc reports results for the quarter ended September 30 - Earnings Summary
Brief: Axonics Q3 Basic EPS USD 0
Axonics Inc expected to post earnings of 13 cents a share - Earnings Preview
Axonics Inc expected to post earnings of 13 cents a share - Earnings Preview